Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.
CONCLUSION: Serum GPC3 is inferior to AFP in the differential diagnosis between HCC and LC. However, the combination of GPC3 and AFP exhibited a much better performance.
PMID: 31113610 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Clinical Trials | Databases & Libraries | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Science | Study | Urology & Nephrology